Trials / Completed
CompletedNCT02962830
Sufentanil Pharmacokinetics After Intra Amniotic Injection
Assessment of Fetal and Maternal Sufentanil Pharmacokinetics After Intra-amniotic Injection
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 8 (actual)
- Sponsor
- University Hospital, Lille · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The fetus may be exposed during pregnancy to nociceptive stimuli because of fetal pathology (e.g., malformation) or a diagnostic or therapeutic procedure. To date, there is very little data and no consensus on fetal analgesia. The aim of the investigators study is to evaluate the pharmacokinetics of Sufentanil after intra amniotic injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sufentanil | intra-amniotic injection of 10 micrograms of Sufentanil |
Timeline
- Start date
- 2017-04-19
- Primary completion
- 2024-05-28
- Completion
- 2024-05-29
- First posted
- 2016-11-11
- Last updated
- 2025-12-03
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02962830. Inclusion in this directory is not an endorsement.